JNJ insider sale: 22,623 shares for $5.53M
Johnson & Johnson insider sale reported.
Rhea-AI Filing Summary
Johnson & Johnson insider sale reported. The filing shows a sale of 22,623 common shares by Timothy Schmid on 02/18/2026 for $5,527,545.45. The form also lists a restricted stock vesting of 1,322 shares on 02/13/2026. A broker listed is Fidelity Brokerage Services LLC with an entry date of 02/20/2026.
Positive
- None.
Negative
- None.
Insights
Routine insider disposition and vesting activity disclosed; no additional qualifiers shown.
The filing records a sale of 22,623 common shares by Timothy Schmid on 02/18/2026 with aggregate proceeds of $5,527,545.45. It also lists a restricted stock vesting of 1,322 shares on 02/13/2026.
These items, as disclosed, are transactional and administrative in nature. Cash‑flow treatment and any trading plan details are not shown in the provided excerpt; subsequent filings would state such mechanics if applicable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did JNJ report in this Form 144?
Did any restricted stock vest for JNJ executives in February 2026?
Which broker handled the reported JNJ transaction in the filing?
Does the Form 144 excerpt state who received the sale proceeds?
Is there any indication this sale was made under a Rule 10b5‑1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.